Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Sterling Partners and its Incubator ’87 Partner with Stella Center for Trauma Symptom Care

Sterling Partners and its investment incubator ‘87 announced today the formation of a new managed services organization (MSO), Stella MSO, LLC, which will provide services to Stella Center, a new model of care for individuals seeking treatment of neurological trauma-related symptoms.

Stella Center provides care to patients with a 20-minute outpatient medical procedure called a modified Stellate Ganglion Block (SGB) that targets the brain’s fight or flight response to help alleviate symptoms related to neurological trauma. These symptoms range from relationship and sleep problems to panic attacks and surges of irritability and afflict those from all walks of life, including military personnel, veterans and first responders. The procedure and Stella Center draw on the years of experience of highly regarded, board-certified anesthesiologist and Stella Center’s Chief Medical Officer Dr. Eugene Lipov. Dr. Lipov has administered the SGB procedure more than 1,000 times in patients with trauma-related symptoms.

The formation of the MSO and its first partnership with a physical center for care, located just outside of downtown Chicago, was led by Sterling Partners (“Sterling”) Chairman and Co-Founder Steven Taslitz. Taslitz was introduced to Dr. Lipov and licensed psychologist and veteran trauma specialist Dr. Shauna Springer in early 2019, and together they sought to create a patient-first center designed to improve the lives of those impacted by trauma. Furthermore, the partnership complemented Taslitz’s desire to build and scale businesses that benefit veteran communities, just as his team did through an investment in Black Rifle Coffee Company. Together Dr. Lipov, Dr. Springer, Taslitz, and ‘87 are building a platform that could expand nationally to increase access to this method of care, and in communities with large concentrations of military personnel.

“The Department of Veterans Affairs estimates that Post-Traumatic Stress Disorder will affect 7% to 8% of the population at some point in life,” explained Taslitz. “When we were approached by Dr. Lipov to assist him in expanding his model that seeks to meaningfully improve people’s lives, we couldn’t help but roll up our sleeves. Stella Center is an opportunity for us to draw on our years of experience in healthcare investing and our entrepreneurial roots. We’re excited to be on the forefront of addressing the challenge of effective and scalable trauma-related symptom care.”

Through the creation of Stella’s MSO, Sterling and ’87 provide Stella Center strategic guidance on finance, talent, branding, and marketing. Sterling has nearly 40 years of investment and business-building experience and a long-standing practice in multi-unit healthcare services. With Sterling’s addition of ‘87, which brings expertise in growth marketing and brand building, the partnership with Stella Center seemed particularly well-suited. Dr. Lipov controls the center itself and the services provided there, alongside CEO James R. Williams. Williams, like Sterling, is a proven healthcare leader, having previously expanded and led U.S. care networks for companies including DaVita, Vein Clinics of America, Accelitech, and ProCure.

Stella Center’s first physical location is now open at 2425 22nd St., Suite 101, Oak Brook, IL, 60523. It is administering treatment as appropriate while adhering to physical distancing requirements. Its call center is also open to consult with potential patients and outline treatment options through its telehealth platform. With Drs. Lipov and Springer’s direction, Stella Center is evaluating opening new brick and mortar locations, focused in active duty and veteran-heavy geographies, and hiring top-tier clinical staff.

“This is a promising time in the advancement of care for the biological and neurological effects of trauma,” added Lipov. “I’m thrilled to be working with Sterling Partners and ’87, who have extensive experience in building great healthcare organizations and positive patient experiences. Our goal is to provide hope and healing to patients struggling with trauma-related symptoms.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy